FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

40630011000001105: Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jun 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2247521000001117 Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2247541000001110 Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has AMP Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) true Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Is a Fentanyl 600microgram sublingual tablets sugar free 30 tablet true Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Fentanyl true Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Fentanyl citrate true Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start